Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells

被引：0
作者：
Cheng Jiang
Junming Guo
Zhe Wang
Bingxiu Xiao
Hyo-Jung Lee
Eun-Ok Lee
Sung-Hoon Kim
Junxuan Lu
机构：
[1] University of Minnesota,The Hormel Institute
[2] Ningbo University School of Medicine,Cancer Preventive Material Development Research Center (CPMDRC), College of Oriental Medicine
[3] Kyunghee University,undefined
[4] Hoegi-dong,undefined
来源：
Breast Cancer Research | / 9卷
关键词：
Tamoxifen; Fulvestrant; Estrogen Stimulation; Faslodex; Decursinol Angelate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 44 条
[21]   iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity [J].
María Inés Diaz Bessone ;
Lorena Simón-Gracia ;
Pablo Scodeller ;
María de los Angeles Ramirez ;
María Amparo Lago Huvelle ;
Galo J. A. A. Soler-Illia ;
Marina Simian .
Journal of Nanobiotechnology, 17
[22]   Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: A unifying concept in anti-hormone resistance [J].
Balaburski, Gregor M. ;
Dardes, Rita C. ;
Johnson, Michael ;
Haddad, Bassem ;
Zhu, Fang ;
Ross, Eric A. ;
Sengupta, Surojeet ;
Klein-Szanto, Andres ;
Liu, Hong ;
Lee, Eun Sook ;
Kim, Helen ;
Jordan, V. Craig .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (02) :387-398
[23]   Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells [J].
Cliff Hurd ;
Sumi Dinda ;
Nidhi Khattree ;
V K Moudgil .
Oncogene, 1999, 18 :1067-1072
[24]   Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells [J].
Hurd, C ;
Dinda, S ;
Khattree, N ;
Moudgil, VK .
ONCOGENE, 1999, 18 (04) :1067-1072
[25]   Changes in the expression and binding properties of the estrogen receptor in MCF-7 breast cancer cells during growth inhibition by tamoxifen and cisplatin [J].
Otto, AM ;
Schubert, S ;
Netzker, R .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (04) :305-311
[26]   A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells [J].
Wang, Bo ;
Li, Dongping ;
Rodriguez-Juarez, Rocio ;
Farfus, Allison ;
Storozynsky, Quinn ;
Malach, Megan ;
Carpenter, Emily ;
Filkowski, Jody ;
Lykkesfeldt, Anne E. ;
Kovalchuk, Olga .
BMC CANCER, 2018, 18
[27]   A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells [J].
Bo Wang ;
Dongping Li ;
Rocio Rodriguez-Juarez ;
Allison Farfus ;
Quinn Storozynsky ;
Megan Malach ;
Emily Carpenter ;
Jody Filkowski ;
Anne E. Lykkesfeldt ;
Olga Kovalchuk .
BMC Cancer, 18
[28]   The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling [J].
Martin, LA ;
Pancholi, S ;
Farmer, I ;
Johnston, SRD ;
Dowsett, M .
BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) :S28-S29
[29]   The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling [J].
L-A Martin ;
S Pancholi ;
I Farmer ;
SRD Johnston ;
M Dowsett .
Breast Cancer Research, 7
[30]   Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen [J].
Irna, IK ;
Itoh, T ;
Chen, SU .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 97 (04) :360-368
12345